Population pharmacodynamic analysis of hemoglobin A1c-lowering effects by adding treatment of DPP-4 inhibitors (sitagliptin) in type 2 diabetes mellitus patients based on electronic medical records
Keywords: Sitagliptin; Pioglitazone; Hemoglobin A1c; Population pharmacodynamics; Electronic medical records;